| scholarly article | Q13442814 |
| P50 | author | John V. Williams | Q55189885 |
| Sharon J. Tollefson | Q116679889 | ||
| James E. Crowe, Jr. | Q37366747 | ||
| P2093 | author name string | David W Wright | |
| Scott A Miller | |||
| P2860 | cites work | Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation | Q45421033 |
| Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex | Q45740595 | ||
| The paramyxovirus fusion protein forms an extremely stable core trimer: structural parallels to influenza virus haemagglutinin and HIV-1 gp41. | Q45749386 | ||
| Structure and function study of paramyxovirus fusion protein heptad repeat peptides | Q46409835 | ||
| Human metapneumovirus infections in young and elderly adults. | Q51685002 | ||
| An iterative method for improved protein structural motif recognition. | Q52256049 | ||
| A trimeric structural domain of the HIV-1 transmembrane glycoprotein. | Q54155492 | ||
| LearnCoil-VMF: computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins | Q57394586 | ||
| Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling | Q73944932 | ||
| Amino acid substitution matrices from protein blocks | Q24563220 | ||
| Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution | Q27617533 | ||
| Structural basis for paramyxovirus-mediated membrane fusion | Q27617867 | ||
| Structural characterization of the human respiratory syncytial virus fusion protein core | Q27628799 | ||
| The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion | Q27631011 | ||
| Short constrained peptides that inhibit HIV-1 entry | Q27639916 | ||
| Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides | Q27764897 | ||
| A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition | Q28317348 | ||
| Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion | Q28345073 | ||
| Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region | Q28360391 | ||
| Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection | Q28369033 | ||
| Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion | Q28646673 | ||
| A spring-loaded mechanism for the conformational change of influenza hemagglutinin | Q28646856 | ||
| Twilight zone of protein sequence alignments | Q29614388 | ||
| Mechanisms of viral membrane fusion and its inhibition | Q29616090 | ||
| Virus-cell and cell-cell fusion | Q30469833 | ||
| Protein design of an HIV-1 entry inhibitor | Q32067748 | ||
| Mutational analysis of residues in the coiled-coil domain of human immunodeficiency virus type 1 transmembrane protein gp41 | Q33785997 | ||
| A newly discovered human pneumovirus isolated from young children with respiratory tract disease | Q33845279 | ||
| Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein | Q33853545 | ||
| Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein | Q33855371 | ||
| Analysis of the genomic sequence of a human metapneumovirus | Q34130526 | ||
| Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children | Q35697523 | ||
| Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion | Q37712954 | ||
| The modelling of drug response | Q40292814 | ||
| Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion | Q40666989 | ||
| Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups | Q40694024 | ||
| Paramyxovirus fusion: a hypothesis for changes | Q40767649 | ||
| Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation | Q40885459 | ||
| Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection | Q41172119 | ||
| Heptad breaks in alpha-helical coiled coils: stutters and stammers | Q41209193 | ||
| Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein | Q41487431 | ||
| Modelling the structure of the fusion protein from human respiratory syncytial virus | Q44009340 | ||
| Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion | Q44255473 | ||
| Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120. | Q45216915 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Human metapneumovirus | Q743338 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 141-149 | |
| P577 | publication date | 2006-10-11 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region | |
| P478 | volume | 81 |
| Q39076394 | Antiviral therapy for respiratory viral infections in immunocompromised patients. |
| Q27658463 | Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein |
| Q36586874 | Breaking in: human metapneumovirus fusion and entry |
| Q99625242 | Entry Inhibitors: Efficient Means to Block Viral Infection |
| Q42571145 | Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years |
| Q35945710 | Genomic analysis of four human metapneumovirus prototypes |
| Q38892410 | HRA2pl peptide: a fusion inhibitor for human metapneumovirus produced in tobacco plants by transient transformation |
| Q42133760 | Human metapneumovirus G protein is highly conserved within but not between genetic lineages |
| Q27694039 | Human metapneumovirus in adults |
| Q37059705 | Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation |
| Q36422618 | Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus |
| Q41040045 | Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus |
| Q37068968 | Integrin alphavbeta1 promotes infection by human metapneumovirus |
| Q38896046 | Modulation of Host Immunity by the Human Metapneumovirus. |
| Q38524373 | New Approaches for Immunization and Therapy against Human Metapneumovirus |
| Q41493353 | Prediction of antiviral peptides derived from viral fusion proteins potentially active against herpes simplex and influenza A viruses |
| Q38961397 | Residues of the human metapneumovirus fusion (F) protein critical for its strain-related fusion phenotype: implications for the virus replication cycle |
Search more.